Sucraziff O Tablet contains Sucralfate 1 gm and Oxetacaine 20 mg, a combination formulated to help manage gastric ulcers, acidity, gastritis, heartburn, and related gastrointestinal discomfort. It helps in protecting the stomach lining while providing relief from pain and irritation associated with excessive gastric acid. The formulation is widely used in gastroenterology practice for supporting the healing of ulcerative and inflammatory conditions of the digestive tract.
Sucralfate works by forming a protective barrier over ulcers and damaged areas of the stomach and intestinal lining. This protective coating shields the affected tissues from stomach acid, bile salts, and digestive enzymes, thereby promoting natural healing. By helping preserve the integrity of the gastrointestinal mucosa, Sucralfate contributes significantly to ulcer management and symptom relief.
Oxetacaine is a local anesthetic that helps provide rapid relief from pain, burning sensations, and discomfort associated with hyperacidity and ulcerative conditions. Its action complements the protective effects of Sucralfate by reducing irritation and improving patient comfort. The combination is commonly prescribed for conditions involving acid-related mucosal damage where both protection and symptomatic relief are required.
With the increasing prevalence of lifestyle-related digestive disorders, acidity complaints, and gastric ulcer conditions, Sucraziff O Tablet offers strong market demand in the gastroenterology segment. Its proven combination, broad clinical acceptance, and consistent prescription pattern make it a valuable product for retailers and distributors. The product presents excellent opportunities for business growth within the expanding gastrointestinal healthcare market.